DG SANTE published the agenda for the upcoming SCoPAFF Residues meeting on 13-14.02.2023.
EFSA conclusion on peer review Purpureocillium lilacinum strain PL11
EFSA published its opinion on the peer review of Purpureocillium lilacinum strain PL11.
Approval Purpureocillium lilacinum PL11 published
On 05.01.2022 the approval of Purpureocillium lilacinum strain PL11 was published in the Official Journal.
Agenda SCoPAFF Legislation October 2021 published
On 05.10.2021 the agenda for the upcoming SCoPAFF Legislation meeting of 21-22.10.2021 was published.
Minutes SCoPAFF Legislation July 2021 published
On 16.09.2021 the summary report/minutes of the SCoPAFF Legislation meeting of 05-06.07.2021 were published on the DG SANTE website.
SCoPAFF Legislation July meeting, Polish report
The Polish competent authority published its report of the SCoPAFF Legislation meeting of 05-06.07.2021.
Polish report SCoPAFF Legislation May 2021
The Polish competent authority published a report on the SCoPAFF meeting of 19-20.05.2021.
Agenda SCoPAFF Legislation 05-06 July 2021
DG SANTE published the agenda for the upcoming SCoPAFF Legislation meeting on 5-6July.
SCoPAFF Legislation agenda 19-20 May 2021
The agenda for the SCoPAFF Legislation meeting of 19-20.05.2021 is published on the SANTE website.
Poland report on SCoPAFF Legislation 24-25 March published
A report from the Polish delegation to the SCoPAFF Legislation meeting of 24-25 March 2021 was published.
Agenda SCoPAFF Legislation 24-25 March published
The agenda for the upcoming SCoPAFF Legislation meeting was published on the Commission website.
RoQ 12.01.2021
Candida oleophila strain O, eugenol, geraniol, limestone, Purpureocillium lilacinum strain PL 11, thymol
RoQ 23.12.2020
asulam sodium, benthiavalicarb, bifenthrin, carbon dioxide, Purpureocillium lilacinum PL11
RoQ 10.12.2020
deltamethrin, spirotetramat, Purpureocillium lilacinum strain PL 11
RoQ 26.10.2020
spiroxamine, metribuzin, Purpureocillium lilacinum PL11
The deadlines for these three substances are extended by EFSA for various reasons, as explained in a letter to the Commission.
RoQ 12.10.2020
S-metolachlor, fluoxastrobin, metconazole, triflusulfuron, metribuzin, propiconazole, dithianon, Purpureocillium lilacinum strain PL 11